Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(39 sites)
United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado Mayo Clinic Hospital - Florida, Jacksonville, Florida Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida Piedmont Physicians Medical Oncology - Atlanta, Atlanta, Georgia The University of Chicago Medical Center - Duchossois Center for Advanced Medicine, Chicago, Illinois